Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Evaluation With Safety Run-in of Stereotactic Ablative Body Radiation for T1-2a N1 Non-Small Cell Lung Cancer

NCT03321760 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT03321760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03321760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Evaluation With Safety Run-in of Stereotactic Ablative Body Radiation for T1-2a N1 Non-Small Cell Lung Cancer
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Withdrawn
Start date
January 1, 2022
Completion date
December 31, 2027
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer